LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Sangamo Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Sangamo Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Genomic Medicines for Neurodegenerative Diseases Sangamo Therapeutics, Inc. is pioneering the development of intravenously-administered genomic medicines for neurodegenerative diseases, presenting a significant opportunity for partnerships and collaborations in the healthcare sector.

Strategic Partnership with Genentech The recent strategic partnership with Genentech highlights Sangamo's ability to attract major players in the industry, signaling a strong market position and potential for expanding sales channels through synergistic collaborations.

Financial Expansion and Funding Success Securing $50 million upfront in a financing deal with Roche's Genentech signifies financial stability and growth potential for Sangamo, creating opportunities for further investment and business expansion.

Acquisition Interest from Vanguard Group Vanguard Group's acquisition of a stake in Sangamo Therapeutics indicates investor confidence in the company's growth prospects, offering a potential avenue for strategic partnerships and increased market visibility.

Innovative Therapies and Clinical Trial Advancements Sangamo's development of epigenetic regulation therapies and advancements in clinical trials present a compelling value proposition for pharmaceutical companies looking to enhance their product portfolio or collaborate on cutting-edge treatments.

Similar companies to Sangamo Therapeutics, Inc.

✕

Access Insights for Sangamo Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Sangamo Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sangamo Therapeutics, Inc. Tech Stack

Sangamo Therapeutics, Inc. uses 8 technology products and services including OneTrust, Microsoft Outlook, Prototype, and more. Explore Sangamo Therapeutics, Inc.'s tech stack below.

  • OneTrust
    Cookie Compliance
  • Microsoft Outlook
    Email
  • Prototype
    Javascript Frameworks
  • Module Federation
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines
  • HSTS
    Security
  • Tailwind CSS
    UI Frameworks

Media & News

Sangamo Therapeutics, Inc.'s Email Address Formats

Sangamo Therapeutics, Inc. uses at least 1 format(s):
Sangamo Therapeutics, Inc. Email FormatsExamplePercentage
FLast@sangamo.comJDoe@sangamo.com
97%
LastFi@sangamo.comDoeJo@sangamo.com
1%
FMiddleLast@sangamo.comJMichaelDoe@sangamo.com
1%
First@sangamo.comJohn@sangamo.com
1%

Frequently Asked Questions

Where is Sangamo Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc.'s main headquarters is located at 7000 Marina Blvd Brisbane, California 94005 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Sangamo Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Sangamo Therapeutics, Inc.'s main corporate office by phone at
✕

Access Insights for Sangamo Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Sangamo Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-510-970-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sangamo Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc. is a publicly traded company; the company's stock symbol is SGMO.

What is Sangamo Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc.'s official website is sangamo.com and has social profiles on LinkedIn.

How much revenue does Sangamo Therapeutics, Inc. generate?

Minus sign iconPlus sign icon As of August 2024, Sangamo Therapeutics, Inc.'s annual revenue reached $75M.

What is Sangamo Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sangamo Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of August 2024, Sangamo Therapeutics, Inc. has approximately 318 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. M.Chief Executive Officer And President: A. M.Chief Development Officer: N. D.. Explore Sangamo Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Sangamo Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Sangamo Therapeutics, Inc. use?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc.'s tech stack includes OneTrustMicrosoft OutlookPrototypeModule FederationAmazon Web ServicesYoast SEOHSTSTailwind CSS.

What is Sangamo Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc.'s email format typically follows the pattern of . Find more Sangamo Therapeutics, Inc. email formats with LeadIQ.

How much funding has Sangamo Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of August 2024, Sangamo Therapeutics, Inc. has raised $24M in funding. The last funding round occurred on Mar 22, 2024 for $24M.

When was Sangamo Therapeutics, Inc. founded?

Minus sign iconPlus sign iconSangamo Therapeutics, Inc. was founded in 1995.
Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com.

✕

Access Insights for Sangamo Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Sangamo Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
7000 Marina Blvd Brisbane, California 94005 US
Phone number
✕

Access Insights for Sangamo Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Sangamo Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-510-970-****
Website
sangamo.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SGMO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1995
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $24M

    Sangamo Therapeutics, Inc. has raised a total of $24M of funding over 7 rounds. Their latest funding round was raised on Mar 22, 2024 in the amount of $24M.

  • $50M$100M

    Sangamo Therapeutics, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $24M

    Sangamo Therapeutics, Inc. has raised a total of $24M of funding over 7 rounds. Their latest funding round was raised on Mar 22, 2024 in the amount of $24M.

  • $50M$100M

    Sangamo Therapeutics, Inc.'s revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Sangamo Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Sangamo Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.